- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:54 | DataMeds AI subsidiary adds GLP-1 drugs, reports July revenue | 5 | Investing.com | ||
| 13:50 | DataMEDS AI, Inc.: DataMeds AI Provides Update on Corexa Health's Pharmacy Division | 317 | ACCESS Newswire | GLP-1 agonist drugs now availableIntegration of online store CorexaRx.com into Health Lives Here app now completeMedical foods Forzet & Galectovid, and dietary supplement Tollovid now availableRevenue... ► Artikel lesen | |
| Mo | DataMeds AI renames pharmacy subsidiaries to Corexa | 1 | Investing.com | ||
| Mo | DataMEDS AI, Inc.: DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division | 995 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx... ► Artikel lesen | |
| Fr | DataMeds AI, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| Do | DataMEDS AI, Inc.: DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date | 407 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx... ► Artikel lesen | |
| DATAMEDS AI Aktie jetzt für 0€ handeln | |||||
| 05.08. | DataMEDS AI, Inc.: DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here" | 438 | ACCESS Newswire | Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient... ► Artikel lesen | |
| 04.08. | DataMeds AI, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.07. | DataMEDS AI, Inc.: DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid and Galactovid | 643 | ACCESS Newswire | Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company")... ► Artikel lesen | |
| 29.07. | DataMEDS AI, Inc.: DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License | 546 | ACCESS Newswire | Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX PlatformHealthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT... ► Artikel lesen | |
| 27.07. | DataMEDS updates meme coin distribution record date to August 7 | 2 | Investing.com | ||
| 27.07. | DataMEDS AI verschiebt Stichtag für Meme-Coin-Ausschüttung und erhöht Zuteilungsverhältnis | 3 | Investing.com Deutsch | ||
| 27.07. | DataMEDS AI, Inc.: DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders | 374 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| 22.07. | DataMEDS AI, Inc.: DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets | 420 | ACCESS Newswire | Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS... ► Artikel lesen | |
| 21.07. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.07. | Wellgistics Health, Inc. Officially Changes Corporate Name To DataMEDS AI, Inc. | 338 | PR Newswire | Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data
TAMPA, Fla.... ► Artikel lesen | |
| 20.07. | Wellgistics Health, Inc.: Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders | 622 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| 15.07. | Wellgistics Health appoints Brett Thompson as consulting CTO | 2 | Seeking Alpha | ||
| 15.07. | Wellgistics Health ernennt Brett Thompson zum beratenden Chief Technology Officer | 1 | Investing.com Deutsch | ||
| 15.07. | Wellgistics Health, Inc.: Wellgistics Health Appoints Brett Thompson as Chief Technology Officer | 436 | ACCESS Newswire | Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 / Wellgistics Health, Inc. (the "Company" or "Wellgistics")... ► Artikel lesen |
1 2 3 4 5 Weiter >>
102 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CANOPY GROWTH | 0,862 | +0,14 % | Canopy Growth beschleunigt Europa-Expansion und stellt Turnaround-Plan vor | ||
| EYEPOINT | 11,400 | +0,88 % | EyePoint, Inc. - 10-Q, Quarterly Report | ||
| FILANA THERAPEUTICS | 0,838 | +0,12 % | Filana Therapeutics, Inc.: Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update | AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for... ► Artikel lesen | |
| COMPASS PATHWAYS | 12,200 | +5,17 % | Warum Lillys 3,8-Milliarden-Dollar-Deal den Psychedelika-Sektor verändert - und warum Emyria jetzt in den Fokus rücken könnte | ||
| CORBUS PHARMACEUTICALS | 7,940 | +0,51 % | Corbus Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | ||
| DARE BIOSCIENCE | 1,460 | +1,39 % | Daré Bioscience, Inc.: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies | Each year, an estimated six million women in the United States acquire a high-risk HPV infection - and there are no FDA-approved treatments DARE-HPV development is backed by a $10 million U.S. government... ► Artikel lesen | |
| CITIUS PHARMACEUTICALS | 0,692 | -3,94 % | Citius Pharmaceuticals, Inc. - 8-K, Current Report | ||
| ELEDON PHARMACEUTICALS | 3,160 | +1,94 % | Natera, Eledon Partner On Kidney Transplant Monitoring Test For Phase 3 Trial; Stock Up | WASHINGTON (dpa-AFX) - Cell-free DNA testing company Natera, Inc. (NTRA) and Eledon Pharmaceuticals, Inc. (ELDN) announced on Thursday that they have entered into a partnership to use Natera's... ► Artikel lesen | |
| EXICURE | 0,965 | +3,21 % | Exicure, Inc.: Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance | WILMINGTON, Del., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics... ► Artikel lesen | |
| COSMOS HEALTH | 0,186 | -0,85 % | Cosmos Health Inc.: Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels | Digital subscription platform brings together the Company's proprietary consumer health products across consumer (B2C) and corporate (B2B) channelsCustomers can begin through one of three paths: a free... ► Artikel lesen | |
| CHINA SXT PHARMACEUTICALS | 3,037 | -2,38 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenDE0005118806 11 88 0 Solutions AG 07.08.2026 DE000A41YFQ4 11 88 0 Solutions AG 10.08.2026 Tausch 5:1CA49752E1060 Radiant... ► Artikel lesen | |
| CHAMPIONS ONCOLOGY | 4,200 | -3,23 % | Champions Oncology, Inc.: Champions Oncology Reports Record Annual Revenue of $59 Million | Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / July 27, 2026 / Champions Oncology, Inc. (Nasdaq:CSBR), a global leader in clinically relevant oncology... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 7,940 | -0,25 % | CUMBERLAND PHARMACEUTICALS INC - 10-Q, Quarterly Report | ||
| CDT EQUITY | 2,960 | -2,31 % | XFRA ZK70: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCDT EQ. NEW 2026... ► Artikel lesen | |
| ANBIO BIOTECHNOLOGY | 8,650 | +1,17 % | Anbio Biotechnology - 6-K, Report of foreign issuer |
Das Unternehmen DATAMEDS AI INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,32 % bei einem Aktienkurs von 1,330 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DATAMEDS AI INC finden Sie auf Wallstreet Online.